Outer capsid protein P8 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
Outer capsid protein P8 antibody; Structural protein P8) [Cleaved into: Outer capsid protein P8'; Small peptide 1 antibody; Sp1)] antibody
Uniprot No.

Target Background

Function
The outer capsid protein P8 is a self-assembling protein that forms the icosahedral outer capsid of the virus. This capsid exhibits T=13 symmetry, measures approximately 70 nm in diameter, and is composed of 780 P8 protein molecules.
Protein Families
Phytoreovirus outer capsid protein P8 family
Subcellular Location
[Outer capsid protein P8]: Virion. Host cytoplasm.

Q&A

What is the Outer capsid protein P8 and what is its role in phytoreoviruses?

Outer capsid protein P8 is a structural protein that forms the external layer of the double-shelled capsid in phytoreoviruses. These viruses possess two concentric capsid layers - the inner layer formed by P3 protein and the outer layer formed by P8 protein . Functionally, P8 plays critical roles in viral morphogenesis and infection cycles, including:

  • Contributing to the protective outer shell surrounding the viral genome

  • Participating in packaging the viral genome and enzymes required for transcription

  • Mediating secretion of assembled viral particles from infected cells

  • Facilitating viral transmission between hosts

The P8 protein's structural arrangement creates a filamentous capsid that protects the viral genetic material while enabling efficient viral replication and transmission . This protein represents an important antigenic target for antibody development in research applications.

How do P8 and P3 proteins interact during viral particle assembly?

The interaction between P8 and P3 proteins represents a critical stage in phytoreovirus morphogenesis. Experimental studies have revealed several key aspects of this interaction:

  • When P3 and P8 proteins are co-expressed in Spodoptera frugiperda cells, they co-localize within cells and are released as spherical clusters

  • In contrast, when P3 proteins are expressed without P8, they remain cell-associated as demonstrated by confocal microscopy

  • Cryo-electron microscopy analysis shows that secreted P3-P8 complexes form double-layered virus-like particles (VLPs) structurally indistinguishable from intact viral particles

This process appears to involve sequential assembly, where P3 forms the inner capsid layer while interacting with viral genomic material, and P8 subsequently assembles around this structure to form the protective outer shell. The specific protein-protein interaction domains mediating P3-P8 binding remain an active area of investigation, with structural studies suggesting multiple contact points between these proteins that facilitate proper assembly and secretion.

What are the primary methods for detecting and characterizing P8 antibodies?

Several complementary methodological approaches are employed for detecting and characterizing P8 antibodies in research settings:

TechniqueApplicationOptimization Considerations
Western BlottingDetecting antibodies against denatured P8 protein5% milk blocking (1h at room temperature); antibody incubation for 16h at 4°C
ImmunofluorescenceVisualizing P8 in cellular contexts; co-localization studiesFixation protocol selection to preserve native P8 epitopes
Flow CytometryQuantitative analysis of antibody binding to intact viral particlesOptimization of antibody concentration and incubation conditions
ELISAHigh-throughput detection and antibody titer determinationSelection of appropriate coating conditions for native P8 structure
Cryo-electron MicroscopyStructural characterization of antibody-P8 interactionsSample preparation and image processing parameters

When validating new detection methods for P8 antibodies, researchers should implement appropriate controls to ensure specificity, including:

  • Uninfected cell controls

  • Isotype-matched control antibodies

  • Competitive inhibition with purified P8 protein

  • Cross-reactivity assessment with related viral proteins

The selection of detection method should be guided by the specific research question, with consideration given to whether native or denatured P8 conformations are being targeted.

How do mutations in the P8 protein affect antibody recognition and neutralization?

Mutations in viral capsid proteins can significantly impact antibody recognition and neutralization efficacy. For P8 protein, these effects are influenced by several factors:

  • Viral capsid proteins are highly antigenic, stimulating antibodies that recognize specific epitopes on the virus surface

  • Epitopes are often formed by multiple protein loops coming together in the assembled capsid structure

  • Mutations within epitope regions can disrupt structural features recognized by antibodies

  • Selection pressure from antibodies can drive the emergence of escape mutations

When investigating how P8 mutations affect antibody binding, researchers should implement a systematic approach:

  • In vitro selection experiments exposing virus to P8-specific antibodies

  • Deep sequencing to identify emerging mutations under antibody pressure

  • Structural mapping of mutations onto the P8 protein structure

  • Functional assays to determine impacts on:

    • Antibody binding affinity (measured by SPR or BLI)

    • Neutralization efficacy

    • Viral fitness and replication

    • P3 interaction and viral assembly

Understanding the molecular basis of antibody escape is critical for developing antibody reagents with broader detection capabilities and for designing strategies to overcome viral immune evasion.

What are the methodological considerations when using cryo-electron microscopy to study P8 antibody-capsid interactions?

Cryo-electron microscopy (cryo-EM) has emerged as a powerful technique for studying virus-antibody complexes at near-atomic resolution. Optimizing cryo-EM for P8 antibody-capsid studies requires addressing several methodological challenges:

  • Sample preparation: For P8-containing viral particles or VLPs, researchers must optimize purification protocols to ensure sample homogeneity. The P3-P8 complexes form double-layered structures that require careful preparation for visualization .

  • Data collection parameters: The assembled phytoreoviruses containing P8 display specific dimensions (spherical clusters with defined morphology) . Imaging parameters should be optimized accordingly, including:

    • Defocus range: Typically -1.0 to -3.0 μm for optimal contrast

    • Electron dose: 40-60 e-/Ų total dose with frame-based collection

    • Magnification: Selection based on desired resolution and detector characteristics

  • Image processing challenges: For P8 antibody-capsid complexes, specialized approaches may be needed:

    • Symmetry considerations during reconstruction

    • Focused classification to resolve antibody density

    • Local refinement of antibody-binding regions

  • Integration with other techniques: Complementary approaches such as hydrogen-deuterium exchange mass spectrometry or mutational analyses can validate cryo-EM findings and provide a comprehensive understanding of P8 antibody binding mechanisms.

Successful implementation of these methodological considerations has enabled researchers to visualize how phytoreovirus P8 proteins assemble into virus-like particles that are structurally indistinguishable from intact viral particles .

How does the secretion of virus-like particles mediated by P8 protein differ between various insect cell lines?

The P8-mediated secretion of virus-like particles (VLPs) can vary significantly between different insect cell lines. Understanding these variations requires systematic comparative studies:

Cell LineObserved P8-Mediated SecretionKey Considerations
Spodoptera frugiperda (Sf9/Sf21)Efficient secretion of P3-P8 VLPs demonstrated Standard system for studying P8 function
High Five™ (Trichoplusia ni)Variable secretion efficiency compared to Sf9May offer higher expression levels
Drosophila S2 cellsLimited data on P8 secretionDifferent glycosylation patterns
Mammalian cellsP8 secretion pathways may differ from insect cellsImportant for translation to vertebrate systems

Methodologically, comparing VLP secretion across cell lines requires:

  • Standardized expression systems using identical promoters and vectors

  • Quantitative analysis methods including:

    • ELISA with standard curves

    • Nanoparticle tracking analysis

    • Western blotting with densitometry

  • Time-course studies examining secretion kinetics

  • Subcellular localization analysis using:

    • Confocal microscopy with fluorescently tagged P8/P3

    • Cell fractionation with subsequent immunoblotting

    • Live-cell imaging to track protein trafficking

  • Secretion pathway investigations using inhibitors of different secretory components

Research has demonstrated that in Spodoptera frugiperda cells, P8 effectively mediates the secretion of assembled VLPs when co-expressed with P3 protein, resulting in structures that resemble authentic viral particles . These findings have important implications for both basic virology research and biotechnological applications.

What are the challenges in distinguishing between specific and non-specific binding when characterizing new P8 antibodies?

Characterizing the specificity of new antibodies against P8 protein presents several methodological challenges:

  • Conformational epitopes: P8 likely forms complex three-dimensional structures when assembled into viral particles, presenting epitopes that may not exist in the same conformation in denatured or monomeric protein . This necessitates comparing antibody binding using multiple techniques:

    • Native vs. denaturing Western blots

    • ELISA using intact viral particles vs. recombinant protein

    • Immunoprecipitation studies

  • Cross-reactivity with related proteins: For phytoreoviruses, researchers must verify that antibodies against P8 do not cross-react with P3 (inner capsid protein) or other structural proteins . Validation approaches include:

    • Absorption studies with purified proteins

    • Competition assays

    • Testing against closely related viral species

  • Background binding in complex samples: When working with field or clinical samples, non-specific binding can complicate interpretation. Strategies to address this include:

    • Multiple negative controls (uninfected samples, isotype controls)

    • Optimization of blocking conditions

    • Pre-absorption steps to remove cross-reactive antibodies

  • Batch-to-batch variability: Ensuring consistent antibody performance requires:

    • Standardized production and purification methods

    • Quantitative binding assays for quality control

    • Long-term stability testing

Implementing these methodological approaches helps ensure that newly developed P8 antibodies demonstrate the specificity required for reliable research applications.

How can epitope mapping techniques be optimized for P8 antibodies?

Epitope mapping for P8 antibodies requires a strategic combination of techniques to comprehensively characterize antibody binding sites:

TechniqueApplication for P8 Epitope MappingOptimization Strategies
Peptide ArraysIdentification of linear epitopesDesign overlapping peptides (15-20 amino acids) with 5-10 residue overlap; consider cyclized peptides to mimic structural loops
Competition AssaysGrouping antibodies targeting similar regionsPurify monoclonal antibody panel; label reference antibodies; develop binding assays with appropriate controls
Mutational AnalysisIdentifying critical residues for antibody bindingStructure-guided selection of mutation sites; implement high-throughput mutagenesis; ensure mutations don't disrupt protein folding
Structural ApproachesHighest resolution information about epitopesUse Fab fragments rather than whole IgG; screen multiple antibody-antigen ratios; employ computational docking

For P8 specifically, which likely contains conformational epitopes formed by multiple regions coming together in the assembled capsid , researchers should:

  • Consider the quaternary structure of assembled P8 in the viral capsid

  • Map identified epitopes onto structural models of the assembled virus

  • Correlate epitope locations with functional data about neutralization mechanisms

  • Compare epitopes across different P8 variants to identify conserved recognition sites

Integration of multiple epitope mapping approaches provides the most comprehensive characterization of P8 antibody binding sites, enabling better understanding of neutralization mechanisms and informing the development of improved antibody reagents.

What are the current contradictions in the literature regarding P8 protein's role in viral infection?

The literature surrounding P8 protein's role in viral infection presents several areas where data appear contradictory or where significant knowledge gaps exist:

  • Mechanism of secretion: While studies demonstrate that P8 is necessary for the secretion of virus-like particles from insect cells , the molecular details remain incompletely understood. Some research suggests direct interaction with cellular secretory machinery, while other data point to P8-induced modifications of membrane properties.

  • Structural requirements for function: Although cryo-EM studies have visualized double-layered particles containing P3 and P8 proteins , the specific domains and residues critical for various P8 functions have not been consistently defined across different studies.

  • Host range determination: Contradictory data exist regarding whether mutations in P8 affect the ability of phytoreoviruses to replicate in different insect vectors or plant hosts.

  • Immunological significance: While some studies suggest anti-P8 antibodies are highly neutralizing, others indicate limited neutralization potential compared to antibodies targeting other viral components.

These contradictions likely stem from:

  • Variations in experimental systems and methodologies

  • Differences in viral strains and isolates

  • Limited structural information about P8 in different functional states

  • Technical challenges in studying the assembly process

Methodologically, addressing these contradictions requires:

  • Standardized experimental systems across research groups

  • Comprehensive mutagenesis studies with consistent functional readouts

  • Integration of structural and functional data

  • Direct comparison of different viral strains within the same experimental framework

How do post-translational modifications of P8 protein affect antibody binding and function?

Post-translational modifications (PTMs) of viral capsid proteins can significantly impact their antigenic properties and interactions with antibodies. For P8 protein, these effects should be systematically investigated:

Modification TypePotential Impact on P8 Antibody BindingMethodological Approaches
PhosphorylationMay alter conformational epitopes through charge changesMass spectrometry analysis; phosphomimetic mutations; comparative binding assays
GlycosylationCould affect accessibility of protein epitopesGlycoprotein-specific staining; glycosidase treatment; mass spectrometry
UbiquitinationMay influence P8 stability and epitope availabilityImmunoprecipitation with anti-ubiquitin antibodies; proteasome inhibition studies
SUMOylationCould alter protein interactions and surface presentationExpression of tagged SUMO constructs; mutation of SUMO sites

When investigating how PTMs affect P8 antibody interactions, researchers should:

  • Compare antibody binding to P8 isolated from authentic viral particles versus recombinant expression systems

  • Analyze PTM patterns across different viral strains and growth conditions

  • Develop modification-specific antibodies to detect PTM status

  • Assess how PTMs affect critical P8 functions such as interaction with P3 and secretion of viral particles

Understanding the relationship between P8 PTMs and antibody binding is essential for developing detection tools with consistent performance across different experimental conditions and sample types. Modifications may create neo-epitopes or mask existing epitopes, potentially altering the specificity and sensitivity of antibody-based detection methods.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.